Page results
-
This page is to help prepare you and the family for your child’s radiotherapy treatment under a general anaesthetic.
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
-
An ILR is a sealed metal and plastic device, which contains a battery and electronic circuits. ILR is offered to patients who have symptoms / possible symptoms that could be result of an arrhythmia.
-
Initial results suggest the treatment has the potential to alter the course of the disease.
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
An easy to read guide to having radiotherapy at UCLH
-
POEMS syndrome is a rare condition caused by the body producing abnormal plasma cells (a type of blood cell which produces antibodies to fight off infections).
-
The number of NHS funded sensors that you can receive in every shipment is based on each sensor lasting the full number of days as advertised. We are unable to provide additional sensors.
-
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
File results
-
FOI/2023/0525 - Senior doctors/ consultants/ junior doctors pay
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0568 - Adverse reactions to the Astra Zeneca Covid vaccine
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2023/0606 - Carbon emissions 2019/20 to 2022/23
-
FOI/2023/0632 - Whittington Health & UCLH Partnership Development Committee
-
FOI/2023/0678 - Number of retired doctors who returned to work
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2023/0672 - Treatment with dermatology and respiratory medicine
-
FOI/2023/0667 - Training in informed consent for doctors